blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2379539

EP2379539 - AMINO ACID ESTER PRODRUGS AND THE USE THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.02.2013
Database last updated on 14.09.2024
Most recent event   Tooltip08.02.2013Application deemed to be withdrawnpublished on 13.03.2013  [2013/11]
Applicant(s)For all designated states
Bayer Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
[2011/43]
Inventor(s)01 / MEIBOM, Daniel
Dönhoffstr. 80
51373 Leverkusen / DE
02 / LERCHEN, Hans-Georg
Sürderstr. 3
51375 Leverkusen / DE
03 / VAKALOPOULOS, Alexandros
Heinrich-Heine-Str. 79a
40721 Hilden / DE
04 / ALBRECHT-KÜPPER, Barbara
Heidestr. 9
42289 Wülfrath / DE
05 / NELL, Peter
Briller Höhe 12
42115 Wuppertal / DE
06 / KELDENICH, Jörg
Damaschkeweg 49
42113 Wuppertal / DE
07 / ZIMMERMANN, Katja
Bockumer Str. 370 B
40489 Düsseldorf / DE
08 / KRENZ, Ursula
Am Kloster 33
42799 Leichlingen / DE
 [2011/43]
Representative(s)(deleted)
[2011/43]
Application number, filing date09760499.503.12.2009
WO2009EP08618
Priority number, dateDE2008106256616.12.2008         Original published format: DE102008062566
[2011/43]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2010072315
Date:01.07.2010
Language:DE
[2010/26]
Type: A1 Application with search report 
No.:EP2379539
Date:26.10.2011
Language:DE
The application published by WIPO in one of the EPO official languages on 01.07.2010 takes the place of the publication of the European patent application.
[2011/43]
Search report(s)International search report - published on:EP01.07.2010
ClassificationIPC:C07D413/12, A61K31/4439
[2011/43]
CPC:
C07D413/12 (EP,US); A61K31/4439 (EP,US); A61P43/00 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/06 (EP);
A61P9/10 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR 
TitleGerman:AMINOSÄUREESTER-PRODRUGS UND IHRE VERWENDUNG[2011/43]
English:AMINO ACID ESTER PRODRUGS AND THE USE THEREOF[2011/43]
French:PROMÉDICAMENTS D'ESTERS D'ACIDES AMINÉS ET LEUR UTILISATION[2011/43]
Entry into regional phase18.07.2011National basic fee paid 
18.07.2011Designation fee(s) paid 
18.07.2011Examination fee paid 
Examination procedure18.07.2011Examination requested  [2011/43]
09.05.2012Despatch of a communication from the examining division (Time limit: M04)
20.09.2012Application deemed to be withdrawn, date of legal effect  [2013/11]
26.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/11]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.05.2012
Fees paidRenewal fee
12.12.2011Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.12.201204   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO0125210  (BAYER AG [DE], et al) [A] 1-13 * the whole document *;
 [A]WO03053441  (BAYER AG [DE], et al) [A] 1-13 * page 50 - page 54; claims 1-11 * * page 6, line 16 - line 20 *;
 [YDP]WO2009015776  (BAYER HEALTHCARE AG [DE], et al) [YDP] 1-13 * page 193 - page 199; claims 1-13 * * page 135 - page 137; examples 48,49 * * page 141 - page 142; examples 58,60 * * page 7, line 8 - line 11 *;
 [YP]WO2009015812  (BAYER HEALTHCARE AG [DE], et al) [YP] 1-13* the whole document *;
 [AD]  - BEAUMONT K ET AL, "DESIGN OF ESTER PRODRUGS TO ENHANCE ORAL ABSORPTION OF POORLY PERMEABLE COMPOUNDS: CHALLENGES TO THE DISCOVERY SCIENTIST", CURRENT DRUG METABOLISM, BENTHAM SCIENCE PUBLISHERS, US, (20030101), vol. 4, no. 6, ISSN 1389-2002, pages 461 - 485, XP008058352 [AD] 1 * das ganze Dokument; im besonderen, Seite 469, Tabelle 5 *

DOI:   http://dx.doi.org/10.2174/1389200033489253
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.